Congenital Heart Disease — Truncus Arteriosus

• Embryologic basis: Failure of the conotruncus to divide along the aorticopulmonary septum during weeks 4-6 of gestation prevents normal separation of the common arterial trunk into systemic (aorta), pulmonary (main, right, and left pulmonary arteries), and coronary systems. This results from defective neural crest-derived mesenchymal cell migration into the truncal ridges, preventing formation of the septation complex.

• Hemodynamic consequence—Complete mixing: Because a single trunk overrides an incompletely formed ventricular septum (almost always present), deoxygenated venous blood from the right ventricle and oxygenated blood from the left ventricle completely mix within the trunk. This obligatory right-to-left shunt at the arterial level produces desaturation (SpO₂ typically 75-85%) and cyanosis. Simultaneously, systemic vascular resistance is lower than pulmonary vascular resistance in the newborn period, promoting left-to-right shunt physiology within the trunk, resulting in excessive pulmonary blood flow.

• Pathophysiologic paradox—Simultaneous cyanosis and heart failure: The admixture of oxygenated and deoxygenated blood causes systemic arterial desaturation (cyanosis), while the increased pulmonary blood flow (because pulmonary vascular resistance drops rapidly after birth) leads to pulmonary edema, elevated left atrial pressure, and subsequent biventricular failure. This unique combination of severe cyanosis with signs of pulmonary congestion (unlike simple cyanotic lesions such as tetralogy of Fallot) is pathognomonic. Associated defects include complete atrioventricular canal defects (in ~35% of cases) and abnormal coronary artery origins (in 30%), which may arise from the opposite wall of the trunk and course between the aorta and pulmonary artery, creating risk for sudden cardiac death with exercise.

• DiGeorge syndrome (22q11.2 microdeletion): Present in 30-40% of truncus arteriosus cases; most common syndromic association. Characterized by thymic hypoplasia/aplasia, parathyroid hypoplasia, cleft palate, and cardiac defects (truncus arteriosus, tetralogy of Fallot, interrupted aortic arch). Mechanism involves disrupted neural crest migration affecting cardiac neural crest cells derived from pharyngeal arches 1 and 3.

• Sporadic genetic mutations: Mutations in genes regulating neural crest development and conotruncal septation, including TBX1 (22q11), PITX2, GATA4, and NKX2-5. Most cases arise de novo; autosomal dominant inheritance possible in syndromic forms.

• Maternal risk factors: Maternal diabetes mellitus (particularly pregestational), maternal alcohol consumption during the first trimester, and maternal anticonvulsant exposure (phenytoin, topiramate) increase incidence.

• Chromosomal abnormalities: Associated with trisomy 13, trisomy 18, and trisomy 21, though truncus arteriosus is more specific to 22q11 deletion.

• Cyanosis with congestive heart failure (classic paradox): Affected infants present with visible cyanosis (blue discoloration of skin, lips, mucous membranes) that appears within the first hours to days of life, distinguishing truncus from acyanotic lesions. Paradoxically, signs of pulmonary edema and congestive heart failure develop simultaneously, including poor feeding, tachypnea (respiratory rate >60/min), hepatomegaly, and orthopnea—findings typically seen in left-to-right shunts rather than cyanotic heart disease. This combination should prompt immediate consideration of truncus arteriosus.

• Respiratory distress: Tachypnea, retractions, nasal flaring, and grunting from pulmonary edema secondary to excessive pulmonary blood flow and elevated pulmonary venous pressure. Infants may require supplemental oxygen, but because the right-to-left shunt is fixed at the arterial level, increasing inspired oxygen has minimal effect on SpO₂ (failure to achieve SpO₂ >95% with 100% FiO₂ is characteristic of fixed right-to-left shunts).

• Cardiac auscultatory findings: Single, loud S₂ (because both the pulmonary and aortic components occur at the same time from a single trunk), systolic ejection murmur from increased pulmonary blood flow across the pulmonary orifice (often inaudible if pulmonary vessels arise directly from the common trunk), and early diastolic regurgitation murmur from the truncal valve (which typically straddles the ventricular septum and functions as both aortic and pulmonary valve). Truncal valve insufficiency is present in 50-60% of cases and may be severe, contributing to heart failure.

• Poor perfusion and shock: Inadequate systemic oxygen delivery from mixed arterial blood may cause poor peripheral perfusion, cool extremities, weak pulses, metabolic acidosis, and cardiogenic shock if uncorrected. Severe truncal valve regurgitation may precipitate acute decompensation.

• Mucocutaneous findings (if DiGeorge syndrome present): Cleft palate (30% of DiGeorge/22q11 deletion cases), micrognathia, characteristic hypertelorism and short philtrum, and immune deficiency manifestations (recurrent infections, failure to thrive).

• Chest X-ray: Cardiomegaly with marked enlargement of the central mediastinal silhouette due to the large common trunk and associated cardiac chambers. Increased pulmonary vascular markings ("plethoric" appearance) reflecting excessive pulmonary blood flow and pulmonary edema. An "egg-on-string" appearance is characteristic but not pathognomonic. In severe cases, bilateral alveolar infiltrates consistent with pulmonary edema.

• Electrocardiogram (ECG): Right axis deviation (normal in infants but may be exaggerated) and left ventricular hypertrophy from increased systemic blood flow through the left ventricle and elevated afterload from truncal valve regurgitation. Nonspecific findings; ECG does not establish diagnosis but may reveal associated conditions such as complete atrioventricular canal (prolonged PR interval, axis deviation).

• Echocardiography (transthoracic, two-dimensional and Doppler)—Gold standard diagnostic tool:
• Single arterial trunk arising from the base of the heart, overriding the ventricular septum, confirming the absence of separate aortic and pulmonary ostia
• Ventricular septal defect or common ventricular origin (truncus overrides VSD in ~100% of cases)
• Classification per Van Praagh (most common):
• Type A1: Pulmonary arteries arise from the anterior aspect of the common trunk
• Type A2: Right and left pulmonary arteries arise separately from the common trunk
• Type A3: Pulmonary arteries arise from the descending aorta (rare)
• Type A4: No true pulmonary arteries (lung blood flow from aortic branches)
• Truncal valve morphology and regurgitation: Assessment of cusp number (typically 3-4 cusps, but abnormal), degree of insufficiency by color Doppler, and associated stenosis
• Associated defects: Complete atrioventricular canal (35%), abnormal coronary artery origins (30%), aortic arch hypoplasia or interruption (10%)
• Chamber sizes: Biatrial and biventricular enlargement from volume overload
• Pulmonary artery anatomy: Critical for surgical planning; abnormal origins must be identified

• Cardiac catheterization and angiography (now primarily therapeutic rather than diagnostic): Indicated when echocardiography is inconclusive or to assess hemodynamics, coronary anatomy (essential before surgery to avoid injury), and pulmonary vascular resistance. Angiography with selective trunk injection reveals the single trunk and origin of pulmonary arteries. Pressures show elevated right atrial and pulmonary artery pressures reflecting heart failure.

• Cardiac MRI/CT: Increasingly used to delineate coronary artery origins and course (critical for surgical approach), define aortic arch anatomy, and identify associated lesions. CT angiography provides superior resolution of anomalous coronary origins relative to the aorta and pulmonary artery.

• Genetic testing: 22q11.2 microdeletion testing (FISH or chromosomal microarray) indicated in all patients with truncus arteriosus given high prevalence (30-40%) and implications for family counseling, immunologic evaluation, and syndromic management. DiGeorge syndrome testing should be ordered concurrently with cardiac diagnosis.

• Diagnostic criteria (Van Praagh):

1. 1.Single arterial trunk overrides the VSD
2. 2.Pulmonary arteries arise from the common trunk (not from the right ventricle separately)
3. 3.A single truncal valve (not separate aortic and pulmonary valves)
4. 4.Associated with a VSD (obligatory)

Immediate Management (Newborn Period)

• Prostaglandin E1 (PGE1) infusion: First-line emergency intervention to maintain ductal patency, ensuring continued pulmonary blood flow if pulmonary arteries arise anomalously or if ductal closure compromises pulmonary perfusion. Dose: 0.05-0.1 mcg/kg/min IV titrated to effect (maintain ductal patency, improve systemic oxygenation). PGE1 causes systemic vasodilation, which may worsen systemic hypotension; careful hemodynamic monitoring required.

• Supplemental oxygen and ventilatory support: Although cyanosis is relatively refractory to supplemental oxygen (due to fixed right-to-left shunt), modest improvements may be achieved. Gentle ventilation with permissive hypercapnia to avoid excessive increases in pulmonary blood flow and exacerbation of heart failure; target SpO₂ 75-85% to maintain balance between systemic perfusion and pulmonary vascular load.

• Diuretics (furosemide): First-line for heart failure management. Dose: 1 mg/kg IV/PO q6-8h. Reduces pulmonary edema and improves diastolic function. Careful electrolyte monitoring required (risk of hypokalemia, hyponatremia).

• Inotropic support: Milrinone (0.5 mcg/kg/min IV) preferred over catecholamines in acute decompensation because it provides inotropic support and systemic vasodilation (reducing afterload), which improves systemic perfusion and reduces truncal valve regurgitation burden. Dobutamine (5 mcg/kg/min) alternative if additional chronotropic effect needed.

• Acidosis correction and metabolic optimization: IV sodium bicarbonate if pH <7.2 to improve systemic perfusion and reduce pulmonary vascular reactivity. Correction of anemia, maintenance of normothermia, and management of hypoglycemia critical.

Definitive Treatment—Surgical Repair (Rastel Procedure or Variants)

• Early surgical correction—Timing and indications: Performed urgently within the first days to weeks of life (typically within 1-2 weeks, sometimes emergently in the first 24-48 hours). Early repair is mandatory given the extreme physiologic instability and incompatibility with life beyond infancy. Preoperative stabilization with PGE1, diuretics, and inotropes may buy time for cardiology assessment but should not delay definitive surgery.

• Rastelli procedure (standard technique):

1. 1.Separation of pulmonary arteries from the common trunk using careful dissection under cardiopulmonary bypass with moderate hypothermia (18-20°C) and deep circulatory arrest
2. 2.Reconstruction of the truncal valve (aortic valve after pulmonary separation) or conduit replacement if native valve is severely dysplastic or regurgitant; preservation of native valve preferred when possible
3. 3.Closure of the VSD with a patch to separate left ventricular and aortic outflow
4. 4.Placement of a valved conduit (bioprosthetic or homograft) from the right ventricle to the pulmonary arteries to reestablish pulmonary circulation. Modern practice increasingly favors homografts (cryopreserved aortic or pulmonary allografts) for superior durability in the pediatric population, though long-term degeneration necessitates serial surgical replacements ("conduit exchanges") as the child grows
5. 5.Careful identification and preservation of coronary arteries during dissection; anomalous origins must be recognized to avoid iatrogenic injury (leading cause of perioperative death if injured)

• Alternative approaches:
• Direct pulmonary artery reimplantation (Konno modification): Preferred when pulmonary arteries are anatomically favorable; avoids conduit-related complications
• Valve-sparing techniques: Reconstruction of native truncal valve when regurgitation is mild-moderate and cusps are reasonably formed

• Intraoperative monitoring: Transesophageal echocardiography (TEE) essential for real-time assessment of anatomy, separation quality, conduit function, residual VSD, and truncal/aortic valve competence. Anomalous coronary origins confirmed by direct visualization or angiography.

• Postoperative management:
• Low cardiac output state prophylaxis: Inotropic support (milrinone, dobutamine, or combination) continued in ICU setting
• Anticoagulation: Warfarin (target INR 2-3) for mechanical conduits; consideration for homografts depending on institutional practice and conduit type
• Serial echocardiography: Assessment at 24 hours, 1 week, and 1 month postoperatively to evaluate for conduit insufficiency, stenosis, residual shunt, and ventricular function
• Arrhythmia surveillance: Continuous cardiac monitoring; risk of atrial and ventricular arrhythmias from surgical manipulation and scar formation

Long-term Management

• Serial imaging and hemodynamic monitoring: Regular echocardiography (annually or as indicated) and periodic cardiac catheterization to assess conduit stenosis/regurgitation, ventricular function, and pulmonary vascular resistance. Dobutamine stress echocardiography or cardiac MRI for assessment of ventricular performance.

• Conduit replacement surgery: Multiple "conduit exchanges" anticipated during childhood and adolescence as the patient grows and conduits become relatively stenotic or degenerate. Timing of reoperation typically based on hemodynamic evidence of conduit dysfunction (pressure gradient >40 mmHg) or progressive ventricular dysfunction.

• Antibiotic prophylaxis: Standard endocarditis prophylaxis for dental and invasive procedures (amoxicillin 50 mg/kg orally 1 hour before procedure, or cephalexin/clindamycin if penicillin-allergic) per 2007 AHA guidelines.

• Physical activity restriction: Moderate activity restriction in early postoperative period; gradual return to normal activity as tolerated without symptoms. Strenuous/competitive athletics typically restricted due to risk of sudden cardiac death from anomalous coronary origin or conduit dysfunction; individualized risk assessment recommended.

• Genetic counseling and DiGeorge screening: Genetic testing for 22q11.

Unrepaired lesion (all are time-critical; survival beyond infancy is rare)

• Refractory congestive heart failure and cardiogenic shock: as pulmonary vascular resistance falls over the first days to weeks, pulmonary overcirculation escalates and biventricular volume overload decompensates. Signal: worsening tachypnea, diaphoresis with feeds, hepatomegaly, rising lactate. Emergency.
• Necrotizing enterocolitis / renal hypoperfusion: low diastolic pressure from truncal valve regurgitation and pulmonary run-off steals from the mesenteric and renal beds. Signal: feeding intolerance, bloody stools, pneumatosis, oliguria. Emergency.
• Irreversible pulmonary vascular obstructive disease (Eisenmenger physiology): unrestricted high-pressure, high-flow exposure remodels pulmonary arterioles within months. Signal: paradoxical improvement in tachypnea with worsening cyanosis and a shrinking murmur — the child looks better but is now inoperable.
• Myocardial ischemia/sudden death from anomalous coronary origin: a coronary coursing between the great vessels is compressed with exertion. Signal: syncope, ischemic ST changes, arrest.

Perioperative

• Coronary injury during separation of the pulmonary arteries — the leading cause of operative death; signal is ventricular dysfunction, ST elevation, or refractory arrhythmia on separation from bypass. Emergency.
• Pulmonary hypertensive crisis: reactive pulmonary vasculature responds to acidosis, hypoxia, agitation, or suctioning with acute RV pressure overload. Signal: abrupt desaturation, systemic hypotension, rising RV pressure. Managed with deep sedation, oxygen, alkalinization, and inhaled pulmonary vasodilators (inhaled nitric oxide). Emergency.
• Low cardiac output syndrome and complete AV block (VSD patch adjacent to the conduction axis) — block may require pacing. Emergency if hemodynamically unstable.

Late (post-repair)

• Conduit stenosis or insufficiency with somatic growth: the fixed RV–PA conduit cannot grow, so RV pressure overload recurs; signal is a new/louder systolic murmur, exercise intolerance, rising gradient on echo. Reoperation or transcatheter valve replacement is expected, per the AHA/ACC adult congenital heart disease guideline.
• Progressive truncal (now aortic) valve regurgitation with LV dilation, and branch pulmonary artery stenosis.
• Ventricular and atrial arrhythmias / sudden death from ventriculotomy scar and chronic RV pressure load.
• Infective endocarditis on prosthetic conduit or valve — the AHA endocarditis prophylaxis guideline covers prosthetic valve/material and repaired disease with residual defects.

• The paradox is the diagnosis: a neonate with cyanosis plus pulmonary overcirculation (tachypnea, hepatomegaly, plethoric lung fields on CXR) has a complete-mixing lesion — truncus arteriosus at the top of the list. Cyanosis with decreased pulmonary markings points instead to tetralogy of Fallot, tricuspid atresia, or critical pulmonary stenosis.

• Single loud S₂ is the auscultatory buzzword — one valve, one closure sound. Add a systolic ejection murmur and a decrescendo diastolic murmur of truncal valve regurgitation and the stem is essentially handing you the answer.

• Single best next step after an abnormal newborn pulse-oximetry screen (AAP/AHA critical CHD screening) or cyanosis unresponsive to 100% oxygen is transthoracic echocardiography — not repeat blood gas, not chest CT. Echo defines the single trunk, the obligatory VSD, truncal valve function, and pulmonary artery origins.

• The association examiners test is 22q11.2 deletion (DiGeorge/velocardiofacial): conotruncal defect + hypocalcemic seizures/jitteriness + absent thymic shadow + lymphopenia. Send chromosomal microarray or FISH in every patient. Two management triggers follow: irradiated, leukoreduced, CMV-safe blood products for cardiac surgery, and withholding live vaccines until T-cell function is documented.

• Embryology answer: failure of neural crest–derived mesenchyme to form the spiral aorticopulmonary septum in the conotruncus — the same cell population explains tetralogy of Fallot, interrupted aortic arch, and the parathyroid/thymic derivatives of the pharyngeal pouches.

• Anomalous coronary origin is the hidden landmine — present in a substantial minority, it drives operative mortality and exertional sudden death. If a stem mentions syncope or arrest with exercise after repair, think coronary, not conduit.

• Common distractor: egg-on-a-string on CXR is far more often the intended cue for d-transposition of the great arteries, where a single S₂ can also occur; TGA is distinguished by a narrow mediastinum, minimal murmur, and ductal/atrial-level dependence. Likewise, do not choose a Blalock–Taussig shunt — truncus already has excess pulmonary flow; the answer is early complete repair with VSD closure and an RV-to-PA valved conduit, with lifelong surveillance and anticipated conduit reintervention per the AHA/ACC adult congenital heart disease guideline.